ask="5.61"
ask_size="2000"
average_daily_volume="1407870"
bid="4.00"
bid_size="200"
book_value="-0.08"
change="+0.05"
change_from_200_day_moving_average="-0.19"
change_from_50_day_moving_average="-0.10"
change_from_52_week_high="-2.72"
change_From_52_week_low="1.09"
change_in_percent="+0.99%"
close="5.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.52"
ebitda="-121.76M"
eps_estimate_current_year="-0.67"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="72994000"
high="5.17"
high_52_weeks="7.80"
last_trade_date="3/7/2017"
last_trade_price="5.08"
last_trade_size="150"
last_trade_time="3:59pm"
low="4.91"
low_52_weeks="3.99"
market_capitalization="546.95M"
moving_average_200_day="5.27"
moving_average_50_day="5.18"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.00"
open="4.99"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="-3.61%"
percent_change_from_50_day_moving_average="-1.97%"
percent_change_from_52_week_high="-34.87%"
percent_change_from_52_week_low="+27.32%"
previous_close="5.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="16.93"
revenue="31.98M"
shares_outstanding="107667000"
short_ratio="14.93"
stock_exchange="NCM"
symbol="KERX"
volume="1341693"
weeks_range_52="3.99 - 7.80"
